Erythema multiforme major
Results: 2
| # | Item |
|---|---|
1 | Kwartaalbericht 3e kwartaaljuli 2010 ContentsAdd to Reading ListSource URL: www.lareb.nlLanguage: English |
2![Isotretinoin and the risk of erythema multiforme Final SPC and PL wording agreed by the PhVWP in June 2010 Doc. Ref.: CMDh/PhVWP[removed]Rev 1 July 2010 SUMMARY OF PRODUCT CHARACTERISTICS Section 4.4](https://www.pdfsearch.io/img/39c66627ed2ced46718b026a61306881.jpg "Isotretinoin and the risk of erythema multiforme Final SPC and PL wording agreed by the PhVWP in June 2010 Doc. Ref.: CMDh/PhVWP[removed]Rev 1 July 2010 SUMMARY OF PRODUCT CHARACTERISTICS Section 4.4") | Isotretinoin and the risk of erythema multiforme Final SPC and PL wording agreed by the PhVWP in June 2010 Doc. Ref.: CMDh/PhVWP[removed]Rev 1 July 2010 SUMMARY OF PRODUCT CHARACTERISTICS Section 4.4Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2010-08-05 07:05:26 |